US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 1.110
  • -0.030-2.63%
Close May 6 16:00 ET
  • 1.100
  • -0.010-0.90%
Post 17:53 ET
81.38MMarket Cap12.33P/E (TTM)

About Protalix Biotherapeutics Company

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Company Profile

SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees208
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Websitehttp://www.protalix.com

Company Executives

  • Name
  • Position
  • Salary
  • Dror Bashan
  • Director, President and Chief Executive Officer
  • 2.68M
  • Eyal Rubin
  • Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
  • 1.03M
  • Yaron Naos
  • Senior Vice President, Operations
  • 776.37K
  • Dr. Eliot Richard Forster, M.B.A.,PhD
  • Chairman of the Board
  • 47.99K
  • Dr. Shmuel Ben-Zvi, PhD
  • Independent Director
  • 74.71K
  • Gwen A. Melincoff
  • Independent Director
  • 79.91K
  • Amos Bar Shalev
  • Independent Director
  • 79.91K
  • Dr. Pol F. Boudes,M.D.
  • Independent Director
  • 115.39K
  • Dr. Aharon Schwartz,PhD
  • Independent Director
  • 79.91K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg